Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM
· Real-Time Price · USD
22.45
-0.46 (-2.01%)
At close: Sep 17, 2025, 3:59 PM
22.73
1.25%
After-hours: Sep 17, 2025, 05:55 PM EDT
-2.01% (1D)
| Bid | 22.08 |
| Market Cap | 2.27B |
| Revenue (ttm) | 60.27M |
| Net Income (ttm) | -398.58M |
| EPS (ttm) | -4.5 |
| PE Ratio (ttm) | -4.99 |
| Forward PE | -4.8 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 23.19 |
| Volume | 3,346,388 |
| Avg. Volume (20D) | 2,562,256 |
| Open | 23.00 |
| Previous Close | 22.91 |
| Day's Range | 21.92 - 23.57 |
| 52-Week Range | 13.53 - 35.25 |
| Beta | 2.15 |
| Ex-Dividend Date | n/a |
About BEAM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BEAM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BEAM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBeam Therapeutics Inc. is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+0.63%
BEAM stock has given up its prior gain. Beam Thera...
Unlock content with
Pro Subscription
1 month ago
+0.63%
Beam Therapeutics shares are trading higher after the company announced the FDA has granted regenerative medicine advanced therapy designation status for Beam-101.
2 months ago · schaeffersresearch.com
Top Stock Pick Report: V-Shaped Rallies EverywhereSubscribers to Chart of the Week received this commentary on Sunday, June 22.
3 months ago · seekingalpha.com
Beam Therapeutics: Progress Of BEAM-101 Presses Forward With H2 2025 Data ReleasesPositive results released from updated data with 17 SCD patients with VOC from the phase 1/2 BEACON study. No VOC after engraftment and >60% HbF induction. Additional results of 30 SCD patients from p...